BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kukla M, Adrych K, Dobrowolska A, Mach T, Reguła J, Rydzewska G. Guidelines for Clostridium difficile infection in adults. Prz Gastroenterol 2020;15:1-21. [PMID: 32215122 DOI: 10.5114/pg.2020.93629] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Geum MJ, Kim C, Kang JE, Choi JH, Kim JS, Son ES, Lim SM, Rhie SJ. Broad-Spectrum Antibiotic Regimen Affects Survival in Patients Receiving Nivolumab for Non-Small Cell Lung Cancer. Pharmaceuticals (Basel) 2021;14:445. [PMID: 34066877 DOI: 10.3390/ph14050445] [Reference Citation Analysis]
2 Fabisiak N, Fabisiak A, Chmielowiec-Korzeniowska A, Tymczyna L, Kamysz W, Kordek R, Bauer M, Kamysz E, Fichna J. Anti-inflammatory and antibacterial effects of human cathelicidin active fragment KR-12 in the mouse models of colitis: a novel potential therapy of inflammatory bowel diseases. Pharmacol Rep 2021;73:163-71. [PMID: 33219923 DOI: 10.1007/s43440-020-00190-3] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
3 Elahi M, Nakayama-Imaohji H, Hashimoto M, Tada A, Yamasaki H, Nagao T, Kuwahara T. The Human Gut Microbe Bacteroides thetaiotaomicron Suppresses Toxin Release from Clostridium difficile by Inhibiting Autolysis. Antibiotics (Basel) 2021;10:187. [PMID: 33671889 DOI: 10.3390/antibiotics10020187] [Reference Citation Analysis]
4 Alrawashdeh M, Rhee C, Hsu H, Wang R, Horan K, Lee GM. Assessment of Federal Value-Based Incentive Programs and In-Hospital Clostridioides difficile Infection Rates. JAMA Netw Open 2021;4:e2132114. [PMID: 34714336 DOI: 10.1001/jamanetworkopen.2021.32114] [Reference Citation Analysis]
5 de Jager P, Smith O, Bolon S, Thomas J, Richards GA. Epidemiology of Clostridioides difficile in South Africa. PLoS One 2021;16:e0259771. [PMID: 34813626 DOI: 10.1371/journal.pone.0259771] [Reference Citation Analysis]
6 Ciechanowicz P, Lewandowski K, Szymańska E, Kaniewska M, Rydzewska GM, Walecka I. Skin and gastrointestinal symptoms in COVID-19. Prz Gastroenterol 2020;15:301-8. [PMID: 33777269 DOI: 10.5114/pg.2020.101558] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
7 Vasilescu I, Chifiriuc M, Pircalabioru GG, Filip R, Bolocan A, Lazăr V, Diţu L, Bleotu C. Gut Dysbiosis and Clostridioides difficile Infection in Neonates and Adults. Front Microbiol 2022;12:651081. [DOI: 10.3389/fmicb.2021.651081] [Reference Citation Analysis]
8 El-Deeb W, Fayez M, Elsohaby I, Mkrtchyan HV, Alhaider A. Changes in blood biomarkers in Arabian horses with Clostridium difficile-induced enterocolitis. Comp Immunol Microbiol Infect Dis 2020;73:101525. [PMID: 32877870 DOI: 10.1016/j.cimid.2020.101525] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]